RecruitingNot ApplicableNCT03011541

Stem Cell Ophthalmology Treatment Study II

Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II


Sponsor

MD Stem Cells

Enrollment

500 participants

Start Date

Jan 1, 2016

Study Type

INTERVENTIONAL

Conditions

Summary

This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether stem cell treatments derived from fat tissue or bone marrow can help preserve or improve vision in people with damage to the retina (the light-sensitive layer at the back of the eye) or the optic nerve (the nerve connecting the eye to the brain). **You may be eligible if...** - You have documented, measurable damage to the retina or optic nerve that is unlikely to improve on its own, OR that is getting progressively worse - Your best corrected vision in one or both eyes is 20/30 or worse, AND/OR you have an abnormal visual field in one or both eyes - It has been at least 3 months since any eye surgery, and your condition has been stable - If you are currently on eye medications, your condition has been stable for at least 3 months **You may NOT be eligible if...** - You have had recent or unstable eye disease - You have certain serious medical conditions that make the procedure unsafe - You are pregnant or planning to become pregnant - You are unable to attend the required follow-up visits Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREArm 1

Procedure/ Surgery: RB (Retrobulbar) Retrobulbar injection of Bone Marrow Derived Stem Cells (BMSC) Procedure/Surgery: ST (Subtenon) Subtenon injection of Bone Marrow Derived Stem Cells (BMSC) Procedure/Surgery: IV (Intravenous) Intravenous injection of Bone Marrow Derived Stem Cells (BMSC)


Locations(4)

MD Stem Cells

Westport, Connecticut, United States

MD Stem Cells

Coral Springs, Florida, United States

MD Stem Cells Kobinia Med

Vienna, Austria, Austria

The Saudi-German Hospital

Dubai, United Arab Emirates, United Arab Emirates

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03011541


Related Trials